WEDNESDAY, Oct. 2, 2024 -- Olanzapine may be better than prochlorperazine for reducing refractory nausea in patients with breast cancer starting a...
Vous n'êtes pas connecté
WEDNESDAY, Oct. 2, 2024 -- For patients undergoing breast reconstruction, a 16-fraction course of hypofractionated postmastectomy radiation therapy (PMRT) is noninferior to a 25-fraction conventional course, according to a study presented at the...
WEDNESDAY, Oct. 2, 2024 -- Olanzapine may be better than prochlorperazine for reducing refractory nausea in patients with breast cancer starting a...
MONDAY, Sept. 30, 2024 -- A shorter course of post-mastectomy radiation doesn't jeopardize a patient's chances of successful breast reconstruction, a...
Spiritual beliefs and a historically-based distrust of clinical research may factor into Black patients’ decisions about whether to participate in...
WEDNESDAY, Oct. 2, 2024 -- The PROVIDE model of video consultation leads to a decrease in depressive and anxiety symptoms among primary care patients,...
TUESDAY, Oct. 1, 2024 -- Patients with fast-spreading blood cancer respond well to outpatient treatment with CAR-T therapy, the largest study...
WEDNESDAY, Sept. 25, 2024 -- For patients with obesity, the addition of semaglutide to standard hidradenitis suppurativa (HS) treatments yields...
WEDNESDAY, Oct. 2, 2024 -- For patients with bilateral Meniere disease (MD), features of endolymphatic hydrops correlate with the severity of hearing...
FRIDAY, Sept. 20, 2024 -- For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left...
WEDNESDAY, Oct. 2, 2024 -- Higher doses of buprenorphine for patients with opioid use disorder (OUD) are associated with lower acute care utilization,...
According to two international studies presented at the ESMO Congress 2024, women who breastfeed after receiving treatment for breast cancer,...